Invasive treatment for intermittent claudication

• To test the hypothesis that a primary invasive treatment strategy (surgical or endovascular revascularization) improves health-related quality of life and

In conclusion, we established that a primary strategy of revascularization, when added to best medical treatment and structured non-supervised exercise training, improves quality of

Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not

Absence of long- term benefit of revascularization in patients with intermittent claudication: five-year results from the IRONIC randomized controlled trial.. Circ

In conclusion, this thesis was unable to detect any significant clinical or morphological differences in outcome between CCH and PNF at one week, six months and one and two years

The problem is two-pronged, as Karma needs to take two sched- uling decisions. One is scheduling of a peripheral operations to bring it back to a consistent state compared to the

For patients with IA, it was assumed L-AmB would be followed by oral step-down treatment with either voriconazole (dosed as per SmPC [18]) for patients with IA if the fungal burden

As insufficient amounts of dissolved oxygen render nitrification, an excess of dissolved oxygen in the aerated basin, will in turn, through the return sludge interrupt